ANGIOTENSIN II

Product NDC
68083-553
Requested package NDC
68083-553-01
11-digit product format
680830553
Labeler code
68083
Product ID
68083-553_db7a3372-cd0e-412e-a8e2-90b5fdcf3e3e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ANGIOTENSIN II
Dosage form
INJECTION
Route
INTRAVENOUS
Labeler
Gland Pharma Limited
Application
ANDA216966
Marketing category
ANDA
Marketing start
2025-06-03
Substance
ANGIOTENSIN II
Active strength
2.5 mg/mL
Pharmacologic classes
Vasoconstriction [PE], Vasoconstrictor [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A216966-001ANGIOTENSIN ll ACETATEANGIOTENSIN II ACETATEEQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML)SOLUTION / INTRAVENOUSAP2025-06-03

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A216966-001AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A216966-001ANGIOTENSIN ll ACETATEEQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML)SOLUTION / INTRAVENOUSAP2025-06-0384e616aacf4f…
2026-08-18 06:07:402026-07A216966-001ANGIOTENSIN ll ACETATEEQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML)SOLUTION / INTRAVENOUSAP2025-06-03caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A216966-001ANGIOTENSIN ll ACETATEEQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML)SOLUTION / INTRAVENOUSAP2025-06-03011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A216966-001ANGIOTENSIN ll ACETATEEQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML)SOLUTION / INTRAVENOUSAP2025-06-0331067a03dcf5…
2025-08-23 18:47 UTC2025-08A216966-001ANGIOTENSIN ll ACETATEEQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML)SOLUTION / INTRAVENOUSAP2025-06-036a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A216966-001ANGIOTENSIN ll ACETATEEQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML)SOLUTION / INTRAVENOUSAP2025-06-03a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A216966-001AP184e616aacf4f…
2026-08-18 06:07:402026-07A216966-001AP1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A216966-001AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A216966-001AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08A216966-001AP16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A216966-001AP1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
ANGIOTENSIN II
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ANGIOTENSIN II2.5 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
M089EFU921Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1999007Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
727d1102-fc46-46f8-b78e-fd13f0738fe4Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
130a1d32-6dfa-469f-904c-6e21cbf0f11cProduct name220260317

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68083-553-01ANGIOTENSIN II1 in 1 CARTONINJECTION13
68083-553-01ANGIOTENSIN II1 mL in 1 VIAL, SINGLE-DOSEINJECTION13

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ANGIOTENSIN IIANGIOTENSIN IIGland Pharma Limited727d1102-fc46-46f8-b78e-fd13f0738fe42025-06-04Warnings, Adverse reactionsExact identifier
application applno (ANDA): 216966
application number: ANDA216966
ndc (package): 68083-553-01
ndc (product): 68083-553
ndc11 (package): 68083055301

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1999007angiotensin II 2.5 MG in 1 ML InjectionPSN727d1102-fc46-46f8-b78e-fd13f0738fe43
19990071 ML angiotensin II 2.5 MG/ML InjectionSCD727d1102-fc46-46f8-b78e-fd13f0738fe43
1999007angiotensin II 2.5 MG per 1 ML InjectionSY727d1102-fc46-46f8-b78e-fd13f0738fe43

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
68083-553-01680830553011 VIAL, SINGLE-DOSE in 1 CARTON (68083-553-01) / 1 mL in 1 VIAL, SINGLE-DOSE2025-06-03NoNoCurrent